Mycophenolate mofetil in combination with cyclosporine a (CSA) ± prednisolone versus CsA, methotrexate ± prednisolone for the prophylaxis of acute GvHD after allogeneic stem cell transplantation -: MMF, a new option in GvHD prophylaxis.

被引：0
|
作者：
Kiehl, MG
Linck, D
Schaefer-Eckart, K
Kroeger, M
Bronhaeuser, M
Blau, IW
Wandt, H
Jenke, A
Kienast, J
Armstrong, VW
Basara, N
Schroeder, H
Kraut, L
Fauser, AA
机构：
[1] Clin Hematol Oncol, BMT Unit, Idar Oberstein, Germany
[2] Clin Hematol Oncol, BMT Unit, Nurnberg, Germany
[3] Univ Hosp Munster, Clin Hematol Oncol, Munster, Germany
[4] Univ Hosp Dresden, Dept Hematol Oncol, Dresden, Germany
[5] Free Univ Berlin, Klinikum Benjamin Franklin, Dept Hematol Oncol, D-12200 Berlin, Germany
[6] Univ Hosp Gottingen, Dept Clin Chem, Gottingen, Germany
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2650
引用
收藏
页码：716A / 716A
页数：1
相关论文
共 50 条
  • [11] Cyclosporin A (CSA) and Mycophenolate Mofetil (MMF) vs Cyclosporine A and Steroids for graft-versus-host disease (GVHD) prophylaxis after umbilical cord blood (CB) transplantation
    Ghemlas, Ibrahim
    Siddiqui, Khawar
    Jafri, Rafat
    Barria, Mary
    Amao, Antonette
    Alsaedi, Hawazen
    Alsweedan, Suleimman
    Alahmari, Ali
    Aljerfi, Abdullah
    Alseraihy, Amal
    Ayas, Mouhab
    BONE MARROW TRANSPLANTATION, 2018, 53 : 406 - 406
  • [12] Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic stem cell transplantation
    Kasper, C
    Mügge, L
    Schilling, K
    Scholl, S
    Wollina, K
    Höffken, K
    Sayer, H
    BONE MARROW TRANSPLANTATION, 2002, 29 : S187 - S188
  • [13] Mycophenolate mofetil AUC targeting for GvHD prophylaxis after allogeneic haematopoetic stem cell transplantation
    Freiberg-Richter, J
    Jenke, A
    Pursche, S
    Bonin, M
    Schleyer, E
    Ehninger, G
    Bornhäuser, M
    BONE MARROW TRANSPLANTATION, 2005, 35 : S147 - S147
  • [14] The combination of mycophenolate mofetil, cyclosporine A and methotrexate for prophylaxes of acute GVHD in allogeneic peripheral blood stem cell transplantation.
    Wang, JM
    Song, XM
    Zhang, WP
    Tong, SP
    Hou, J
    Chen, L
    Li, H
    Min, BH
    BLOOD, 2001, 98 (11) : 662A - 662A
  • [15] Bone marrow transplantation (BMT) for chronic myeloid leukemia (CML), the combination of cyclosporine (CSA), methotrexate (MTX) and prednisolone (MP) for prophylaxis of graft-versus-host disease (GVHD).
    Andrade, RJ
    Medeiros, CR
    ZanisNeto, J
    Ogasawara, VS
    Friedrich, MLC
    Bilencourt, MA
    Bonfirm, CMS
    Pasquini, R
    BLOOD, 1996, 88 (10) : 3769 - 3769
  • [16] Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis
    Y Lai
    J Ma
    P Schwarzenberger
    W Li
    Z Cai
    J Zhou
    Z Peng
    J Yang
    L Luo
    J Luo
    D Deng
    Q Li
    Y Zhou
    J Liang
    Bone Marrow Transplantation, 2009, 43 : 61 - 67
  • [17] Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis
    Lai, Y.
    Ma, J.
    Schwarzenberger, P.
    Li, W.
    Cai, Z.
    Zhou, J.
    Peng, Z.
    Yang, J.
    Luo, L.
    Luo, J.
    Deng, D.
    Li, Q.
    Zhou, Y.
    Liang, J.
    BONE MARROW TRANSPLANTATION, 2009, 43 (01) : 61 - 67
  • [18] Clinical and laboratory features of minor ABO incompatible reduced intensity blood hematopoietic cell transplantation using cyclosporin (CsA) vs. CsA/mycophenolate mofetil (CsA/MMF) for graft-vs-host disease (GVHD) prophylaxis.
    Reese, A
    Stevens, WT
    Donohue, T
    Chakrabarti, S
    Wesley, R
    Castro, K
    Fowler, D
    Bishop, MR
    Stroncek, D
    Leitman, S
    Childs, RW
    Bolan, CD
    BLOOD, 2003, 102 (11) : 708A - 708A
  • [19] Unrelated stem cell transplantation (SCT) following a novel reduced intensity conditioning regimen and mycophenolate mophetil (MMF) plus cyclosporin A (CsA) as graft versus host disease (GVHD) prophylaxis.
    Lacerda, JF
    Martins, C
    Carmo, JA
    Lourenco, F
    Juncal, C
    Ligeiro, D
    Martinho, A
    Lacerda, JMF
    BLOOD, 2003, 102 (11) : 430B - 430B
  • [20] GvHD prophylaxis with sirolimus in combination with mycophenolate mofetil in allogeneic stem cell transplantation for high-risk leukaemia patients
    Schleuning, M.
    Judith, D.
    Bertelsmann, A.
    Jedlickova, Z.
    Heshmat, M.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S227 - S227
12345